# Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/dr-margarete-fischer-bosch-institute-of-clinical-pharmacology/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 103.5 |
| Citations | 473,078 |
| City | Stuttgart |
| Country | DE |
| Description | Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology is a research organisation in Stuttgart, DE. OpenAlex records 2,855 works and 473,078 citations for it. 379 researchers list it as their most recent affiliation. |
| Homepage | http://ikp-stuttgart.de |
| OpenAlex ID | https://openalex.org/I4210120009 |
| Researchers | 379 |
| ROR ID | https://ror.org/02pnjnj33 |
| Type | facility |
| Works | 2,855 |

## University papers

- [Reduced Paneth cell α-defensins in ileal Crohn's disease](https://scholariq.org/papers/reduced-paneth-cell-defensins-in-ileal-crohn-s-disease/)
- [NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression](https://scholariq.org/papers/nod2-card15-mutations-in-crohn-s-disease-are-associated-with-diminished-mucosal/)
- [A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors](https://scholariq.org/papers/a-new-molecular-predictor-of-distant-recurrence-in-er-positive-her2-negative/)
- [A Chromosome 8 Gene-Cluster Polymorphism with Low Human Beta-Defensin 2 Gene Copy Number Predisposes to Crohn Disease of the Colon](https://scholariq.org/papers/a-chromosome-8-gene-cluster-polymorphism-with-low-human-beta-defensin-2-gene/)
- [A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study](https://scholariq.org/papers/a-12-gene-pharmacogenetic-panel-to-prevent-adverse-drug-reactions-an-open-label/)
- [From hype to reality: data science enabling personalized medicine](https://scholariq.org/papers/from-hype-to-reality-data-science-enabling-personalized-medicine/)
- [Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process](https://scholariq.org/papers/incorporation-of-pharmacogenomics-into-routine-clinical-practice-the-clinical/)
- [Apheresis therapies for NMOSD attacks](https://scholariq.org/papers/apheresis-therapies-for-nmosd-attacks/)

## University top topics

Showing 8 of 25.

- [Pharmacogenetics and Drug Metabolism](https://scholariq.org/topics/pharmacogenetics-and-drug-metabolism/)
- [Drug Transport and Resistance Mechanisms](https://scholariq.org/topics/drug-transport-and-resistance-mechanisms/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)
- [Estrogen and related hormone effects](https://scholariq.org/topics/estrogen-and-related-hormone-effects/)
- [Pharmacological Effects and Toxicity Studies](https://scholariq.org/topics/pharmacological-effects-and-toxicity-studies/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Genetic Associations and Epidemiology](https://scholariq.org/topics/genetic-associations-and-epidemiology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.